Karyopharm Therapeutics reported 0 in Dividend Yield for its fiscal quarter ending in March of 2025.





Dy Change Date
AbbVie 2.64 0.07 Sep/2026
Abbott 2.55 0.18 Sep/2026
Amgen 2.36 0.35 Sep/2026
AstraZeneca USD 1.98 0.23 Sep/2026
BioCryst Pharmaceuticals 0 0 Mar/2025
Bristol-Myers Squibb 4.04 0.32 Sep/2026
Eli Lilly 0.58 0.02 Sep/2026
Enanta Pharmaceuticals 0 0 Mar/2025
GlaxoSmithKline 2.78 1.93 Sep/2026
J&J 1.95 0.11 Sep/2026
Karyopharm Therapeutics 0 0 Mar/2025
Merck 2.34 0.28 Sep/2026
Nektar Therapeutics 0 0 Mar/2025
Novartis USD 3.28 0.18 Sep/2026
Novartis 3.32 0.22 Sep/2026
Pfizer 6 1.08 Sep/2026
Regeneron Pharmaceuticals 0.58 0.12 Jun/2026
Roche Holding 2.94 0.01 Jun/2026
Sangamo BioSciences 0 0 Mar/2025
Takeda 3.46 0.42 Sep/2026